| Literature DB >> 24801594 |
Liang Gong1, Xiurun Chen1, Chenglan Liu1, Fengliang Jin1, Qiongbo Hu1.
Abstract
Destruxin A (DA) is a cyclo-peptidic mycotoxin from the entomopathogenic fungus Metarhizium anisopliae. To uncover potential genes associated with its molecular mechanisms, a digital gene expression (DGE) profiling analysis was used to compare differentially expressed genes in the hemocytes of silkworm larvae treated with DA. Ten DGE libraries were constructed, sequenced, and assembled, and the unigenes with least 2.0-fold difference were further analyzed. The numbers of up-regulated genes were 10, 20, 18, 74 and 8, as well as the numbers of down-regulated genes were 0, 1, 8, 13 and 3 at 1, 4, 8, 12 and 24 h post treatment, respectively. Totally, the expression of 132 genes were significantly changed, among them, 1, 3 and 12 genes were continually up-regulated at 4, 3 and 2 different time points, respectively, while 1 gene was either up or down-regulated continually at 2 different time points. Furthermore, 68 genes were assigned to one or multiple gene ontology (GO) terms and 89 genes were assigned to specific Kyoto Encyclopedia of Genes and Genomes (KEGG) Orthology. In-depth analysis identified that these genes putatively involved in insecticide resistance, cell apoptosis, and innate immune defense. Finally, twenty differentially expressed genes were randomly chosen and validated by quantitative real-time PCR (qRT-PCR). Our studies provide insights into the toxic effect of this microbial insecticide on silkworm's hemocytes, and are helpful to better understanding of the molecular mechanisms of DA as a biological insecticide.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24801594 PMCID: PMC4011735 DOI: 10.1371/journal.pone.0096170
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Quality assessment of reads in each library.
Quality assessment of reads in each library.
| Sample ID | Total Reads | Total BasePairs | Total Mapped Reads | Perfect Match | < = 2 bp Mismatch | Uni)ue Match | Multi-position Match | Total UnmappeG Reads |
| mapping to reference genes | ||||||||
| 1h-CK | 7,218,527(100.00%) | 353,707,823(100.00%) | 4,338,614(60.10%) | 3,303,737(45.77%) | 1,034,877(14.34%) | 4,203,040(58.23%) | 135,574(1.88%) | 2,879,913(39.90%) |
| 1h-DA | 7,059,269(100.00%) | 345,904,181(100.00%) | 3,976,792(56.33%) | 3,026,423(42.87%) | 950,369(13.46%) | 3,846,164(54.48%) | 130,628(1.85%) | 3,082,477(43.67%) |
| 4h-CK | 7,607,918(100.00%) | 372,787,982(100.00%) | 4,208,364(55.32%) | 3,210,421(42.20%) | 997,943(13.12%) | 4,062,080(53.39%) | 146,284(1.92%) | 3,399,554(44.68%) |
| 4h-DA | 7,262,556(100.00%) | 355,865,244(100.00%) | 3,972,549(54.70%) | 3,025,332(41.66%) | 947,217(13.04%) | 3,825,954(52.68%) | 146,595(2.02%) | 3,290,007(45.30%) |
| 8h-CK | 7,371,616(100.00%) | 361,209,184(100.00%) | 4,119,567(55.88%) | 3,128,946(42.45%) | 990,621(13.44%) | 3,984,631(54.05%) | 134,936(1.83%) | 3,252,049(44.12%) |
| 8h-DA | 7,270,371(100.00%) | 356,248,179(100.00%) | 4,069,945(55.98%) | 3,071,129(42.24%) | 998,816(13.74%) | 3,918,331(53.89%) | 151,614(2.09%) | 3,200,426(44.02%) |
| 12h-CK | 7,007,499(100.00%) | 343,367,451(100.00%) | 4,024,328(57.43%) | 3,087,657(44.06%) | 936,671(13.37%) | 3,879,756(55.37%) | 144,572(2.06%) | 2,983,171(42.57%) |
| 12h-DA | 7,447,287(100.00%) | 364,917,063(100.00%) | 4,387,447(58.91%) | 3,332,790(44.75%) | 1,054,657(14.16%) | 4,226,722(56.76%) | 160,725(2.16%) | 3,059,840(41.09%) |
| 24h-CK | 7,322,620(100.00%) | 358,808,380(100.00%) | 4,381,281(59.83%) | 3,351,541(45.77%) | 1,029,740(14.06%) | 4,231,254(57.78%) | 150,027(2.05%) | 2,941,339(40.17%) |
| 24h-DA | 7,218,751(100.00%) | 353,718,799(100.00%) | 4,388,131(60.79%) | 3,327,038(46.09%) | 1,061,093(14.70%) | 4,209,788(58.32%) | 178,343(2.47%) | 2,830,620(39.21%) |
| mapping to reference genome | ||||||||
| 1h-CK | 7,218,527(100.00%) | 353,707,823(100.00%) | 5,753,578(79.71%) | 4,188,473(58.02%) | 1,565,105(21.68%) | 5,258,986(72.85%) | 494,592(6.85%) | 1,464,949(20.29%) |
| 1h-DA | 7,059,269(100.00%) | 345,904,181(100.00%) | 5,633,325(79.80%) | 4,095,419(58.01%) | 1,537,906(21.79%) | 5,137,525(72.78%) | 495,800(7.02%) | 1,425,944(20.20%) |
| 4h-CK | 7,607,918(100.00%) | 372,787,982(100.00%) | 6,092,604(80.08%) | 4,449,564(58.49%) | 1,643,040(21.60%) | 5,538,986(72.81%) | 553,618(7.28%) | 1,515,314(19.92%) |
| 4h-DA | 7,262,556(100.00%) | 355,865,244(100.00%) | 5,814,310(80.06%) | 4,235,398(58.32%) | 1,578,912(21.74%) | 5,277,498(72.67%) | 536,812(7.39%) | 1,448,246(19.94%) |
| 8h-CK | 7,371,616(100.00%) | 361,209,184(100.00%) | 5,914,326(80.23%) | 4,293,595(58.24%) | 1,620,731(21.99%) | 5,367,432(72.81%) | 546,894(7.42%) | 1,457,290(19.77%) |
| 8h-DA | 7,270,371(100.00%) | 356,248,179(100.00%) | 5,815,639(79.99%) | 4,200,774(57.78%) | 1,614,865(22.21%) | 5,260,111(72.35%) | 555,528(7.64%) | 1,454,732(20.01%) |
| 12h-CK | 7,007,499(100.00%) | 343,367,451(100.00%) | 5,643,292(80.53%) | 4,145,460(59.16%) | 1,497,832(21.37%) | 5,121,247(73.08%) | 522,045(7.45%) | 1,364,207(19.47%) |
| 12h-DA | 7,447,287(100.00%) | 364,917,063(100.00%) | 5,991,286(80.45%) | 4,365,692(58.62%) | 1,625,594(21.83%) | 5,420,779(72.79%) | 570,507(7.66%) | 1,456,001(19.55%) |
| 24h-CK | 7,322,620(100.00%) | 358,808,380(100.00%) | 5,893,436(80.48%) | 4,322,509(59.03%) | 1,570,927(21.45%) | 5,335,314(72.86%) | 558,122(7.62%) | 1,429,184(19.52%) |
| 24h-DA | 7,218,751(100.00%) | 353,718,799(100.00%) | 5,811,085(80.50%) | 4,226,172(58.54%) | 1,584,913(21.96%) | 5,240,312(72.59%) | 570,773(7.91%) | 1,407,666(19.50%) |
Figure 2Screening of more than 2-fold differentially expressed genes in B.mori hemocytes after the treatment of DA in differential time intervals.
Figure 3Summarizing of Gene Ontology functional classification of ten DGEs by comparing DA-treated and un-treated samples in differential time intervals, which described gene products in terms of their associated biological processes, cellular components and molecular functions.
Quantitative Real Time PCR (qRT-PCR) validation of DGE result.
| Gene ID | Protein | Time after treatment | DGE Log2 ratio | qPCR | |
| Primers(5′ to 3′) | Relative expression | ||||
| Bm_nscaf2674_064 | Alkaliphilic serine protease | 1 h | 9.32 | F: GGAGGTTCTGGTTCGGR: | 19.56±2.27 |
| Bm_nscaf2674_063 | alkaliphilic serine protease | 1 h | 5.13 | F: ACGACCAACATTAACCAGTA R: | 10.4±1.70 |
| Bm_nscaf2838_045 | Putative cuticle protein CPH45 | 1 h | 6.77 | F: TGCCATTGTTGAAGGTGC R: | 1.21±0.09 |
| Bm_nscaf2818_064 | chlorophyllide A binding protein precursor | 4 h | 5.46 | F: TACGCTCTCCTGTATTCTTG R: | 1.95+0.132 |
| Bm_nscaf2767_133 | Putative cuticle protein CPH45 | 4 h | 9.36 | F: CGTTGACGAAGCCGAAAT R: | 1.50±0.23 |
| Bm_nscaf2795_018 | Tubulointerstitial nephritis antigen precursor | 8 h | −2.94 | F:TAACCAACAAGGGACCAC R: | −9.04±1.50 |
| Bm_scaffold769_2 | Serine protease precursor | 8 h | 8.90 | F:GGCAACCTCCACAAGC R: | 2.78±0.22 |
| Bm_nscaf2983_049 | trypsin-like protease precursor | 8 h | 9.98 | F: CGACTACGACAATACTGACT R: | 7.95±0.84 |
| Bm_nscaf3013_07 | putative membrane protein precursor | 8 h | 10.12 | F: CCTCGCAGACAACATCAT R: | 3.75±0.45 |
| Bm_nscaf2847_194 | threonine 3-dehydrogenase | 8 h | −3.67 | F: GCGGAGTTGTTAGGAGAG R: | −2.97±0.14 |
| Bm_nscaf3087_01 | hypothetical protein KGM_21246 | 8 h | −8.69 | F: CCAGAATCAACGGCAACA R:TAATGAGGTAGGAAGGAGACT | −5.64±0.66 |
| Bm_nscaf1108_005 | hypothetical protein KGM_05290 | 12 h | 7.29 | F: GAAGGCGTTGATGGAGAA R: | 5.46±0.23 |
| Bm_scaffold721_3 | hypothetical protein KGM_18620 | 12 h | 4.26 | F: GCGGTAGTCTATGTTGTGA R: | 8.27±0.74 |
| Bm_nscaf3003_091 | beta-glucosidase precursor | 12 h | 8.07 | F: GTGGAGATGATGCGAGAG R: | 4.52±0.56 |
| Bm_nscaf463_08 | beta-N-acetylglucosaminidase 3 precursor | 12 h | 9.27 | F: CGACCTCCTGACACATTG R: | 17.3±2.6 |
| Bm_nscaf2818_106 | Bmp-2 protein | 24 h | 4.47 | F: CGTCACCGGGCAACAT R: | 2.98±3.7 |
| Bm_nscaf2931_28 | Fungal protease inhibitor F precursor | 24 h | 3.14 | F: TGGGTGTCCCGAGAATG R: | 1.07±0.11 |
| Bm_nscaf463_19 | Putative serotonin receptor | 24 h | −2.25 | F: GAAGAGCCAAGGACCACT R: | −1.55±0.13 |
| Bm_nscaf2818_106 | bmp-2 protein | 24 h | 2.54 | F: GGCGTTATATCCGTGGAG R: | 7.46±0.65 |
| Bm_nscaf3045_59 | glucosinolate sulfatase | 24 h | −3.07 | F: TGACAATGGCGGTATGAC R: | −6.43±0.63 |
means significant difference existed between the DA treated and control samples.
means no significant difference.
DGE data were generated from two biological repeats. qPCR data were generated by the standard deviation from three biological repeats.
NCBI SRA accession numbers for the treatments at each time point.
| Name | Past the treatment | Accession number |
| 1hCK | 1 h | SRX480635 |
| 1hDA | 1 h | SRX480636 |
| 4hCK | 4 h | SRX480637 |
| 4hDA | 4 h | SRX480638 |
| 8hCK | 8 h | SRX480639 |
| 8hDA | 8 h | SRX480640 |
| 12hCK | 12 h | SRX480641 |
| 12hDA | 12 h | SRX480642 |
| 24hCK | 24 h | SRX480643 |
| 24hDA | 24 h | SRX480644 |